Quality of life and treatment outcomes: Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

Cancer

Volumn 79, Issue 10, 1997, Pages 1977-1986

  Shrader Bogen, Cheryl L ^a,c   Kjellberg, Janice L ^a   McPherson, Carol P ^a   Murray, Charles L ^a,b  

^a Methodist Hospital   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Institute for Research and Education   (United States)

Author keywords

prostatectomy; prostatic neoplasm; quality of life; radiotherapy; treatment outcome

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIGESTIVE SYSTEM FUNCTION DISORDER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; QUALITY OF LIFE; SELF REPORT; SEXUAL DYSFUNCTION; TREATMENT OUTCOME; URINARY DYSFUNCTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; COUNSELING; CROSS-SECTIONAL STUDIES; DEFECATION; DEMOGRAPHY; HUMANS; INCIDENCE; INTESTINAL DISEASES; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); SEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SURVIVAL RATE; TREATMENT OUTCOME; URINATION; UROLOGIC DISEASES;

EID: 0030918534     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1977::AID-CNCR20>3.0.CO;2-R     Document Type: Article

References (37)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
2. Garnick MB. The dilemmas of prostate cancer. Sci Am 1994;270:72-81.
3. Middleton RG. The management of clinically localized prostate cancer: guidelines from the American Urological Association. CA Cancer J Clin 1996;46:249-53.
4. National Institutes of Health Consensus Development Panel. Consensus statement: the management of clinically localized prostate cancer. Adapted from the Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. 1987 Jun 15-17; Bethesda. National Institutes of Health. NCI Monogr 1988;7:3-6.
5. Chodak GW. The role of conservative management in localized prostate cancer. Cancer 1994;74(7 Suppl):2178-81.
6. Hanks GE. Radiotherapy or surgery for prostate cancer. Acta Oncol 1991;30:231-7.
7. Catalona WJ. Management of cancer of the prostate. N Engl J Med 1994;331:996-1004.
8. Kaplan ID, Cox RS, Bagshaw MA. Radiotherapy for prostatic cancer: patient selection and the impact of local control. Urology 1994;43:634-9.
9. Middleton RG. Surgery vs. other treatments for organ confined prostate cancer. Prim Care Cancer 1993;13:41-3,58.
10. Paulson DF, Lin GH, Hinshaw W, Stephani S. The Uro-Oncology Research Group. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1982;128:502-4.
11. Lee WR, Hanks GE, Schultheiss TE, Corn BW, Hunt MA. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen-driven outcome analysis. J Clin Oncol 1995;13:464-9.
12. Mohler JL. Treatment issues in clinically localized prostatic carcinoma [editorial]. J Urol 1995;154:1433-4.
13. Hanks GE, Krall JM, Hanlon AL, Asbell SO, Pilepich MV, Owen JB. Patterns of care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure. Int J Radiat Oncol Biol Phys 1993;28:39-45.
14. Gibbons RP, Correa RJ Jr., Brannen GE, Weissman RM. Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol 1989;141:564-6.
15. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850-7.
16. Fowler FJ Jr., Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 1993;42:622-9.
17. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831-6.
18. Talcott JA, Rieker P, Propert KJ, Clark J, Kantoff CP, Beard C, et al. Long-term complications of treatment for early prostate cancer: 2-year followup in a prospective, multi-institutional outcomes study [abstract]. Proc Annu Meet Am Soc Clin Oncol 1996;15:A644.
19. Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991;21:935-9.
20. Litwin MS. Measuring health related quality of life in men with prostate cancer. J Urol 1994;152:1882-7.
21. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
22. Litwin MS. Health-related quality of life after treatment for localized prostate cancer. Cancer 1995;75(7 Suppl):2000-3.
23. Lim AJ, Brandon AH, Fiedler J, Brickman AL, Boyer CI, Raub WA Jr., et al. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995;154:1420-5.
24. Gburek B, Harmon B, Chodak GW. Quality of life assessment in patients with prostate cancer treated by radical prostatectomy, radiation therapy or a combination [abstract]. J Urol 1992;147(4 Suppl):466A.
25. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th edition. American Joint Committee on Cancer. Philadelphia: JB Lippincott, 1992.
26. Montie JE. Staging of prostate cancer. Cancer 1995;75(7 Suppl):1814-8.
27. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 1994;12:608-16.
28. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9.
29. Gotay CC. Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies. Monogr Natl Cancer Inst 1996;20:1-6.
30. Moinpour CM, Savage M, Hayden KA, Sawyers J, Upchurch C. Quality of life assessment in cancer clinical trials. In: Dimsdale JE, Baum A, editors. Quality of life in behavioral medicine research. Hillsdale, NJ: Lawrence Erlbaum Associates, 1995:79-95.
31. Barry MJ, Fowler FJ Jr., O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-57.
32. Young KJ, Longman AJ. Quality of life and persons with melanoma: a pilot study. Cancer Nurs 1983;6:219-25.
33. Mast ME. Definition and measurement of quality of life in oncology nursing research: review and theoretical implications. Oncol Nurs Forum 1995;22:957-64.
34. SAS Institute Inc. SAS User's Guide: Statistics. Version 5 Edition. Cary, NC: SAS Institute Inc., 1985.
35. Brecher EM, The Editors of Consumer Reports Books. Love, sex, and aging: a consumers union report. Boston: Little, Brown and Company. 1984:311-46.
36. Janus SS, Janus CL. The Janus report on sexual behavior. New York: John Wiley & Sons, Inc., 1993:19-51.
37. Chodak GW. Additional therapy after prostatectomy: implications for patient counseling [editorial]. J Natl Cancer Inst 1996;88:139-40.